Abstract
Cancer cells preferentially metabolize glucose through aerobic glycolysis, a phenomenon known as the Warburg effect. Emerging evidence has shown that long non-coding RNAs (lncRNAs) act as key regulators of multiple cancers. However, it remains largely unexplored whether and how lncRNA regulates glucose metabolism in cancer cells. In this study, we show that lncRNA UCA1 promotes glycolysis in bladder cancer cells, and that UCA1-induced hexokinase 2 (HK2) functions as an important mediator in this process. We further show that UCA1 activates mTOR to regulate HK2 through both activation of STAT3 and repression of microRNA143. Taken together, these findings provide the first evidence that UCA1 plays a positive role in cancer cell glucose metabolism through the cascade of mTOR-STAT3/microRNA143-HK2, and reveal a novel link between lncRNA and the altered glucose metabolism in cancer cells. UCA1 plays a positive role in cancer cell glucose metabolism. UCA1 exerts its role in glycolysis through the cascade of mTOR-STAT3/miR143-HK2.
| Original language | English |
|---|---|
| Pages (from-to) | 951-955 |
| Number of pages | 5 |
| Journal | Cancer Science |
| Volume | 105 |
| Issue number | 8 |
| DOIs | |
| State | Published - Aug 2014 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Aerobic glycolysis
- Cancer metabolism
- LncRNA
- UCA1
- Warburg effect
Fingerprint
Dive into the research topics of 'Long non-coding RNA UCA1 promotes glycolysis by upregulating hexokinase 2 through the mTOR-STAT3/microRNA143 pathway'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver